Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 492

1.

Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).

Oades RD.

Prog Brain Res. 2008;172:543-65. doi: 10.1016/S0079-6123(08)00926-6. Review.

PMID:
18772050
2.

[Meta-analysis of candidate genes in attention-deficit hyperactivity disorder].

Wohl M, Purper-Ouakil D, Mouren MC, Adès J, Gorwood P.

Encephale. 2005 Jul-Aug;31(4 Pt 1):437-47. French.

PMID:
16389711
4.

ADHD and the dopamine transporter: are there reasons to pay attention?

Mazei-Robinson MS, Blakely RD.

Handb Exp Pharmacol. 2006;(175):373-415. Review.

PMID:
16722244
5.

The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder.

Sergeant J.

Neurosci Biobehav Rev. 2000 Jan;24(1):7-12. Review.

PMID:
10654654
6.

Role of the serotonin system in ADHD: treatment implications.

Oades RD.

Expert Rev Neurother. 2007 Oct;7(10):1357-74. Review.

PMID:
17939772
7.
8.

Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.

van der Kooij MA, Glennon JC.

Neurosci Biobehav Rev. 2007;31(4):597-618. Epub 2007 Jan 23. Review.

PMID:
17316796
9.

Candidate gene studies of attention-deficit/hyperactivity disorder.

Faraone SV, Khan SA.

J Clin Psychiatry. 2006;67 Suppl 8:13-20. Review.

10.

The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles.

Oades RD, Sadile AG, Sagvolden T, Viggiano D, Zuddas A, Devoto P, Aase H, Johansen EB, Ruocco LA, Russell VA.

Dev Sci. 2005 Mar;8(2):122-31. Review.

PMID:
15720370
11.
12.

Imaging genetics in ADHD: a focus on cognitive control.

Durston S, de Zeeuw P, Staal WG.

Neurosci Biobehav Rev. 2009 May;33(5):674-89. doi: 10.1016/j.neubiorev.2008.08.009. Epub 2008 Aug 22. Review.

PMID:
18789356
13.

Platelet serotonin concentration in children with attention-deficit/hyperactivity disorder.

Hercigonja Novkovic V, Rudan V, Pivac N, Nedic G, Muck-Seler D.

Neuropsychobiology. 2009;59(1):17-22. doi: 10.1159/000202825. Epub 2009 Feb 17.

PMID:
19221444
14.

Serotonin/dopamine interaction in learning.

Olvera-Cortés ME, Anguiano-Rodríguez P, López-Vázquez MA, Alfaro JM.

Prog Brain Res. 2008;172:567-602. doi: 10.1016/S0079-6123(08)00927-8. Review.

PMID:
18772051
15.

Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents?

Ballon N, Leroy S, Roy C, Bourdel MC, Olie JP, Charles-Nicolas A, Krebs MO, Poirier MF.

Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):1034-41.

PMID:
17671965
16.

Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD).

Quist JF, Barr CL, Schachar R, Roberts W, Malone M, Tannock R, Basile VS, Beitchman J, Kennedy JL.

Mol Psychiatry. 2000 Sep;5(5):537-41.

PMID:
11032388
17.

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. doi: 10.1097/JCP.0b013e318173312f. Review.

PMID:
18480677
18.

Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.

Gabriela ML, John DG, Magdalena BV, Ariadna GS, Francisco de LP, Liz SM, Lino PC, Josefina RG, Ernesto RZ, Carlos CF.

Neurosci Lett. 2009 Feb 27;451(3):257-60. doi: 10.1016/j.neulet.2009.01.004. Epub 2009 Jan 8.

PMID:
19146920
19.

[Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder].

Díaz-Heijtz R, Mulas F, Forssberg H.

Rev Neurol. 2006 Feb 13;42 Suppl 2:S19-23. Review. Spanish.

20.

Proposed animal model of attention deficit hyperactivity disorder.

Kostrzewa RM, Brus R, Kalbfleisch JH, Perry KW, Fuller RW.

Brain Res Bull. 1994;34(2):161-7.

PMID:
7913871

Supplemental Content

Support Center